Purchase Order 75F40120P00105
Award Date 3/11/20
Potential Completion Date 8/31/20
Potential Value $288K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The United States Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grants Services has awarded a $605,098.90 firm fixed price purchase order to Molecular Devices LLC, a division of Danaher Corporation, to provide a High Content Screening System under solicitation FDA-RFQ-75F40123Q00015-CFSAN-2023-114792. The place of performance will be Molecular Devices LLC's facilities located in San Jose, California. The period of performance is from January 12,...
- This federal contract award, valued at $16,520.00, was issued by the Food and Drug Administration (FDA) to Molecular Devices LLC, a for-profit limited liability company based in San Jose, California. The contract is for preventive maintenance services on the FLIPR TETRA system, which is a specialized scientific instrument used for high-throughput cellular screening and drug discovery applications. The contract is a firm-fixed-price purchase order with no set-aside designation. Molecular...
- The Department of Health and Human Services Food and Drug Administration has awarded a Firm Fixed Price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, for a CONFOCAL UPGRADE. The $189,000.00 contract has an August 15, 2023 completion date and was awarded on August 16, 2022. Molecular Devices is a provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company has previously received federal...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $24,946.00, is for a "Service Plan on a Fluorescent Imaging Plate Reader." The contract has no set-aside designation. Molecular Devices LLC is a for-profit limited liability company that specializes in providing high-performance bioanalytical measurement solutions, including sophisticated laboratory...
- This firm fixed price purchase order from the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to Molecular Devices LLC is valued at seventy-three thousand three hundred seventy-four dollars ($73,374) to upgrade an existing ImageXpress Micro Confocal High Content Imaging System (IXMC). The upgrade will include an automated water immersion unit and a 40x Apo LWD 1.15 NA water immersion objective, as requested in the combined synopsis and solicitation to meet the...
- The Department of Health and Human Services' Food and Drug Administration awarded a $120,000 firm fixed price purchase order to Global Life Sciences Solutions USA LLC for a BIACORE 1K+ Upgrade Kit. The prime contractor, a subsidiary of Danaher Corporation, will provide the upgrade kit to support the FDA's work. Performance will take place in Marlborough, Massachusetts over approximately one year. No set aside designation or subcontractors were indicated. The award falls under HHS/FDA programs...
- The Department of Health and Human Services Food and Drug Administration awarded a $1,021,272.00 firm fixed-price purchase order contract to Molecular Devices LLC for the CLONEPIX2 system. The contract has a completion date of September 2, 2024 and was awarded on July 23, 2020. No set-aside designation was used. Molecular Devices LLC is a provider of high-performance bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. Through past...
- This is a $190,019.00 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) and Center for Food Safety and Applied Nutrition (CFSAN) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for an on-site preventative maintenance service agreement for Molecular Devices' Image-Xpress Confocal HT.AI high-content screening system. The contract has an ultimate completion date of September 29, 2027. Molecular Devices is a for-profit limited...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Molecular Devices LLC, a division of Danaher Corporation, for the provision of a SpectraMax Fluorescence Polarization (FP) (Fluorescein) Detection Cartridge. The $12,296.80 contract does not have a set-aside designation and is to be performed in San Jose, California. Molecular Devices, a leading provider of...
- This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...